Does intensified cholesterol lowering provide greater protection from cardiovascular events among patients with stable coronary artery disease?

Hackman, Daniel G.
May 2005
CMAJ: Canadian Medical Association Journal;5/10/2005, Vol. 172 Issue 10, p1294
Academic Journal
Presents a study which investigated whether intensive lowering of low-density lipoprotein cholesterol levels decreases the risk of cardiovascular events among patients with stable coronary artery disease. Methodology; Results; Commentary.


Related Articles

  • LOVASTATIN TO PREVENT ACUTE CORONARY EVENTS WITH AVERAGE CHOLESTEROL LEVELS. MacFarlane, Lori L.; Carek, Peter J. // Journal of Family Practice;Aug1998, Vol. 47 Issue 2, p91 

    The article discusses the role of lovastatin to prevent acute coronary events with average cholesterol levels. Cholesterol reduction with hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with and without preexisting cardiovascular disease reduces the incidence of acute...

  • High Density Lipoprotein and it's Dysfunction. Eren, Esin; Yilmaz, Necat; Aydin, Ozgur // Open Biochemistry Journal;2012, Vol. 6, p78 

    Plasma high-density lipoprotein cholesterol(HDL-C) levels do not predict functionality and composition of high-density lipoprotein(HDL). Traditionally, keeping levels of low-density lipoprotein cholesterol(LDL-C) down and HDL-C up have been the goal of patients to prevent atherosclerosis that...

  • LDL Targets.  // Mayo Clinic Women's Health Source;Mar2007, Vol. 11 Issue 3, p2 

    The article provides information on the recommended low-density lipoprotein (LDL) cholesterol level. Optimal LDL targets depend on one's risk of heart diseases. LDL level should be less than 100 milligrams of cholesterol per deciliter of blood to consider it optimal. For people with known...

  • Implementation Strategies to Improve Non-HDL-Cholesterol Goal Attainment. Virani, Salim S. // Texas Heart Institute Journal;2012, Vol. 39 Issue 2, p228 

    The article discusses the strategies for improving non-high-density-lipoprotein cholesterol (non-HDL-C) goal attainment. It was suggested that non-HDL-C is a better cardiovascular risk marker compared with low-density-lipoprotein cholesterol (LDL-C). The reasons for lower non-HDL-C goal...

  • Torcetrapib: A new strategy to raise HDL cholesterol levels. Bhardwaj, R.; Bhardwaj, P. // Indian Journal of Pharmacology;Feb2005, Vol. 37 Issue 1, p46 

    The article presents a new strategy to raise high-density lipoprotein (HDL) cholesterol levels. HDL cholesterol constitutes a common lipid abnormality in coronary heart disease patients. Agents that increase the HDL cholesterol level are inhibitors of cholesteryl ester transfer protein (CETP)...

  • Atherogenic Lipid Phenotype in a General Group of Subjects. Van, Joanne; Pan, Jianqiu; Charles, M. Arthur; Krauss, Ronald; Wong, Nathan; Xiaoshan Wu // Archives of Pathology & Laboratory Medicine;Nov2007, Vol. 131 Issue 11, p1679 

    Context.—The atherogenic lipid phenotype is a major cardiovascular risk factor, but normal values do not exist derived from 1 analysis in a general study group. Objective.—To determine normal values of all of the atherogenic lipid phenotype parameters using subjects from a general...

  • New Cholesterol Guidelines Establish A Lower LDL Level For Those At Highest Risk.  // RN;Aug2004, Vol. 67 Issue 8, p18 

    Presents an update to national practice guidelines for treating patients with high cholesterol. Setting up a lower goal for low-density lipoprotein cholesterol levels; Consideration of a drug therapy sooner among certain groups of high-risk patients; Review of major clinical trials of statin...

  • Dyslipidemia and cardiovascular risk: the importance of early prevention. MILLER, M. // QJM: An International Journal of Medicine;Sep2009, Vol. 102 Issue 9, p657 

    Strategies aimed at primary prevention provide an outstanding opportunity for reducing the onset and burden of cardiovascular (CV) disease. Lipid abnormalities, including high levels of low-density lipoprotein cholesterol (LDL-C), elevated triglycerides and low levels of high-density lipoprotein...

  • Cholesterol, Lipids, and Statins. Ballantyne, Christie M. // Texas Heart Institute Journal;2005, Vol. 32 Issue 3, p378 

    Deals with the changes in the field of lipids and atherosclerosis. Expansion of the low-density lipoprotein cholesterol target; Evidence supporting lower low-density lipoprotein cholesterol goals; Function of cholesteryl ester transfer protein.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics